Mediterranean diet and the risk of COVID-19 in the 'Seguimiento Universidad de Navarra' cohort.


Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
12 2022
Historique:
received: 03 03 2021
revised: 29 03 2021
accepted: 01 04 2021
pubmed: 4 5 2021
medline: 7 12 2022
entrez: 3 5 2021
Statut: ppublish

Résumé

A potential protection against COVID-19 by a high-quality dietary pattern is to be expected given the biological plausibility supporting the beneficial effects of an adequate dietary intake on the immune system. However, knowledge on the relationship between long-term maintained healthy dietary patterns, such as the Mediterranean diet, and the risk of SARS-CoV-2 infection is still sparse. We longitudinally assessed this association in a well-known Mediterranean cohort. We assessed 9,677 participants from the SUN Project, a prospective cohort of middle-aged university graduates in Spain. We inquired about a positive result in a COVID-19 diagnostic test during the months of February to December 2020. After excluding health professionals (HP), 5,194 participants were included in the statistical analyses (mean age: 52.6, SD: 12.4; 55.2% women). Food habits were assessed at baseline using a previously validated semiquantitative 136-item food frequency questionnaire. Adherence to the Mediterranean diet (cumulative average of 2 repeated measurements 10 years apart) was assessed using the 0-to-9 Mediterranean Diet Score (MDS). We used multivariable logistic regression models to estimate odds ratios and 95% confidence intervals for incident COVID-19 according to the MDS. Among 5,194 non-HP participants, 122 reported to have received a positive COVID-19 diagnostic test. Participants with intermediate adherence to the Mediterranean diet (3 < MDS ≤ 6) had a significantly lower odds of developing COVID-19 (multivariable-adjusted OR = 0.50, 95% CI: 0.34-0.73), and those with the highest adherence (MDS > 6) exhibited the lowest risk (multivariable-adjusted OR = 0.36, 95% CI: 0.16-0.84, p for trend < 0.001) as compared with participants with MDS ≤ 3. This inverse association remained robust within subgroups and in sensitivity analyses. Notwithstanding, no significant associations were observed for health professionals (p for interaction = 0.06). In conclusion, better adherence to the Mediterranean diet may be associated with a lower risk of COVID-19. Our results are applicable only to persons who are not health professionals.

Sections du résumé

BACKGROUND & AIMS
A potential protection against COVID-19 by a high-quality dietary pattern is to be expected given the biological plausibility supporting the beneficial effects of an adequate dietary intake on the immune system. However, knowledge on the relationship between long-term maintained healthy dietary patterns, such as the Mediterranean diet, and the risk of SARS-CoV-2 infection is still sparse. We longitudinally assessed this association in a well-known Mediterranean cohort.
METHODS
We assessed 9,677 participants from the SUN Project, a prospective cohort of middle-aged university graduates in Spain. We inquired about a positive result in a COVID-19 diagnostic test during the months of February to December 2020. After excluding health professionals (HP), 5,194 participants were included in the statistical analyses (mean age: 52.6, SD: 12.4; 55.2% women). Food habits were assessed at baseline using a previously validated semiquantitative 136-item food frequency questionnaire. Adherence to the Mediterranean diet (cumulative average of 2 repeated measurements 10 years apart) was assessed using the 0-to-9 Mediterranean Diet Score (MDS). We used multivariable logistic regression models to estimate odds ratios and 95% confidence intervals for incident COVID-19 according to the MDS.
RESULTS
Among 5,194 non-HP participants, 122 reported to have received a positive COVID-19 diagnostic test. Participants with intermediate adherence to the Mediterranean diet (3 < MDS ≤ 6) had a significantly lower odds of developing COVID-19 (multivariable-adjusted OR = 0.50, 95% CI: 0.34-0.73), and those with the highest adherence (MDS > 6) exhibited the lowest risk (multivariable-adjusted OR = 0.36, 95% CI: 0.16-0.84, p for trend < 0.001) as compared with participants with MDS ≤ 3. This inverse association remained robust within subgroups and in sensitivity analyses. Notwithstanding, no significant associations were observed for health professionals (p for interaction = 0.06).
CONCLUSION
In conclusion, better adherence to the Mediterranean diet may be associated with a lower risk of COVID-19. Our results are applicable only to persons who are not health professionals.

Identifiants

pubmed: 33934925
pii: S0261-5614(21)00190-4
doi: 10.1016/j.clnu.2021.04.001
pmc: PMC8047333
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3061-3068

Informations de copyright

Copyright © 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest All authors declare no conflict of interest.

Références

Endocr Metab Immune Disord Drug Targets. 2021;21(11):1982-1992
pubmed: 33459251
N Engl J Med. 2003 Jun 26;348(26):2599-608
pubmed: 12826634
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Front Endocrinol (Lausanne). 2020 Sep 16;11:574315
pubmed: 33042027
Prostaglandins Leukot Essent Fatty Acids. 2021 Mar;166:102250
pubmed: 33516093
Diabetes Metab Res Rev. 2020 Mar 31;:e3319
pubmed: 32233013
Nutrients. 2021 Jan 30;13(2):
pubmed: 33573169
Public Health Nutr. 2010 Sep;13(9):1364-72
pubmed: 20105389
Metabolism. 2021 Jan;114:154407
pubmed: 33080270
Clin Rheumatol. 2020 Jul;39(7):2085-2094
pubmed: 32474885
Nutr Rev. 2021 Feb 11;79(3):289-300
pubmed: 33570583
Br J Nutr. 2009 Jul;101 Suppl 2:S21-8
pubmed: 19594961
Public Health Nutr. 2006 Feb;9(1A):127-31
pubmed: 16512960
JAMA Netw Open. 2020 Sep 1;3(9):e2019722
pubmed: 32880651
BMC Infect Dis. 2021 Feb 22;21(1):200
pubmed: 33618678
PLoS Med. 2020 Dec 30;17(12):e1003501
pubmed: 33378357
JAMA. 2021 Jan 26;325(4):329-330
pubmed: 33404587
Euro Surveill. 2020 Dec;25(50):
pubmed: 33334400
JAMA Netw Open. 2021 Feb 1;4(2):e210369
pubmed: 33576820
Nutrients. 2018 Mar 31;10(4):
pubmed: 29614726
Front Endocrinol (Lausanne). 2020 Sep 30;11:579401
pubmed: 33101211
BMJ Evid Based Med. 2021 Feb;26(1):1-2
pubmed: 32651302
Obes Rev. 2020 Nov;21(11):e13128
pubmed: 32845580
Nutrients. 2020 Apr 02;12(4):
pubmed: 32252338
Nutrition. 2021 Feb;82:111047
pubmed: 33277150

Auteurs

R Perez-Araluce (R)

University of Navarra, Department of Preventive Medicine and Public Health, Irunlarrea 1, 31008 Pamplona, Navarra, Spain.

M A Martinez-Gonzalez (MA)

University of Navarra, Department of Preventive Medicine and Public Health, Irunlarrea 1, 31008 Pamplona, Navarra, Spain; CIBER Fisiopatología de La Obesidad y Nutrición, Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0, 28029 Madrid, Spain; IdiSNA, Navarra Institute for Health Research, Irunlarrea 3, 31008 Pamplona, Navarra, Spain; Department of Nutrition, Harvard T. H. Chan School of Public Health, 677 Huntington Ave, Boston, MA 02115, USA.

C I Fernández-Lázaro (CI)

University of Navarra, Department of Preventive Medicine and Public Health, Irunlarrea 1, 31008 Pamplona, Navarra, Spain; IdiSNA, Navarra Institute for Health Research, Irunlarrea 3, 31008 Pamplona, Navarra, Spain; IQVIA, Madrid, Spain.

M Bes-Rastrollo (M)

University of Navarra, Department of Preventive Medicine and Public Health, Irunlarrea 1, 31008 Pamplona, Navarra, Spain; CIBER Fisiopatología de La Obesidad y Nutrición, Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0, 28029 Madrid, Spain; IdiSNA, Navarra Institute for Health Research, Irunlarrea 3, 31008 Pamplona, Navarra, Spain.

A Gea (A)

University of Navarra, Department of Preventive Medicine and Public Health, Irunlarrea 1, 31008 Pamplona, Navarra, Spain; CIBER Fisiopatología de La Obesidad y Nutrición, Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0, 28029 Madrid, Spain; IdiSNA, Navarra Institute for Health Research, Irunlarrea 3, 31008 Pamplona, Navarra, Spain.

S Carlos (S)

University of Navarra, Department of Preventive Medicine and Public Health, Irunlarrea 1, 31008 Pamplona, Navarra, Spain; IdiSNA, Navarra Institute for Health Research, Irunlarrea 3, 31008 Pamplona, Navarra, Spain. Electronic address: scarlos@unav.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH